Key facts for KBLI 21021
The essentials a foreign investor needs to know before reading the rest of this page.
The essentials a foreign investor needs to know before reading the rest of this page.
Closed to foreign equity — Indonesian capital must be 100% under Pres. Reg. 10/2021. Foreign investors typically work via commercial / IP / off-take agreements with an Indonesian-owned licensee instead.
No foreign capital permitted — entities operating under KBLI 21021 must be 100% Indonesian-owned. The standard PT PMA route is unavailable.
High-risk activity — requires NIB + full Operating License (Izin) to operate commercially. NIB alone enables only the preparation stage; an Operating License must be obtained before invoicing or production starts.
Statutory licensing turnaround: 7 days once we submit the application — on top of the 2–3 weeks for PT PMA incorporation. We coordinate the full sequence end-to-end.
Issuing authority for PMA: Menteri/Kepala Badan — specific to foreign-owned entities under this KBLI.
BPOM registration mandatory: a separate Indonesian FDA marketing authorization (NIE) is required before any product is marketed. Facility must be CPOB-certified.
Ongoing reporting: quarterly LKPM (Investment Activity Report) to BKPM plus 10 sector-specific obligations. We file these on your behalf as part of monthly compliance — you stay out of the OSS portal entirely.
Diperbarui terakhir · Bersumber dari OSS Indonesia
This group includes businesses that process various extracts and simplicia, galenic preparations, additives or other materials, both active and inactive, that are altered or unaltered, used in the processing of traditional medicine, even if not all of these materials are present in the final product.
Regulasi BUPM (Bidang Usaha Penanaman Modal) Indonesia menempatkan kode ini dalam salah satu dari lima kategori. Untuk perusahaan dengan pemegang saham WNI, batasan investasi asing dan ketentuan khusus PMA tidak berlaku — aturan di bawah mencakup yang relevan untuk operator lokal.
KBLI 21021 dibatasi pada kepemilikan Indonesia 100% menurut Perpres 10/2021. Sebagai investor lokal (pemegang saham WNI atau perusahaan 100% lokal) ini menguntungkan Anda: kegiatan ini tertutup untuk modal asing, mengurangi lapis kompetisi. Pendirian PT lokal mudah dijalankan.
Konteks sektor yang berlaku untuk KBLI 21021 di luar proses OSS umum. Konfirmasi dengan kementerian terkait sebelum komitmen modal.
Indonesia requires BPJPH Halal certification for an expanding range of consumer-product categories. This KBLI's activities fall in scope — see what's required and when.
OTC pharmaceuticals must hold Halal certification by October 2029; prescription drugs follow by 2034. The bar for pharma is high — every excipient, gelatin source, and processing aid must trace back to Halal-certified suppliers. Plan an 8-12 month certification project. We coordinate BPJPH alongside the BPOM marketing authorisation that any pharma product needs anyway.
Review your formulation, supply chain, and facility against BPJPH criteria. Identify ingredients or processes that need swapping.
An accredited Halal Inspection Body (LPPOM-MUI is the largest) audits the facility and reviews documentation.
The Halal certificate is issued under the BPJPH register and the Halal label can be applied to packaging.
An honest read of the situation, plus the structures that work in practice. We've handled all of these — book a call to walk through your specific plan.
This KBLI is reserved to 100% Indonesian capital under Pres. Reg. 10/2021. Foreign investors cannot own shares in an entity registered for this code. The honest paths forward are: (1) operate a different but related KBLI that's open to PMA, (2) partner with a fully Indonesian-owned licensee under a commercial / IP / supply agreement (not equity), or (3) explore a Special Economic Zone where the rule may be relaxed.
The cleanest path: operate a related but open KBLI. For example, foreign investors blocked from primary commodity production frequently succeed with the processing, distribution, branding, or export-trade codes upstream or downstream of the restricted activity.
The data below is the official OSS regulatory profile for this code. It applies to qualifying Indonesian operators (or to your operating partner). Foreign investors won't file these directly, but it's useful context when structuring a partnership or commercial arrangement.
Foreign investors:the licensing matrix below is for context only — direct PMA registration isn't possible for this code. See pathways above for what actually works.
Dokumen dan kapabilitas yang harus dipenuhi pada saat pendaftaran
Kewajiban kepatuhan dan pelaporan selama operasional
Otoritas yang menerbitkan izin tergantung pada situasi Anda.
| Otoritas | Berlaku saat |
|---|---|
| Menteri/Kepala Badan | Seluruhnya |
| Menteri/Kepala Badan | PMA |
PB UMKU permits sit on top of the main NIB and Sertifikat Standar — each is issued by a different ministry, and only when a specific operational activity is performed. This KBLI carries 1 candidate permit across 1 regulator; most operations only need a handful. Emerhub maps your operation to the exact set, files them, and tracks renewals.
BPOM (National Agency of Drug & Food Control). Applies to drugs, processed food, traditional medicine, cosmetics, and health supplements — produced, imported, repackaged, or distributed for human consumption. BPOM is the gating regulator; product registration is required before any commercial sale.

Several restricted codes have higher or full PMA caps inside designated KEK zones (Sanur Health, Lido, Mandalika) or the Batam Free Trade Zone — manufacturing, logistics, and IT services especially. The IUK regime under BP Batam relaxes ownership rules selectively in exchange for export orientation. We assess whether your operation can benefit. See the BP Batam IUK guide for the requirements.
A 100% Indonesian-owned operating entity can hold the restricted licence while you contract with it commercially. We structure these arrangements deliberately — without nominee shareholding, which is unenforceable and increasingly scrutinised.
These siblings are usable by a foreign-owned PT PMA — they have a Large-scale licensing matrix and aren't on a restricted list. Each has its own context badge so you can pick by trade-off.
Class-level prerequisites that apply to every operator under this KBLI, independent of business scale. These commonly include minimum capital rules for PMA entities and spatial-planning (KKPR) conformance.
Penjelasan sederhana tentang klasifikasi ini dan jenis usaha yang termasuk di dalamnya.
KBLI 21021 adalah kode Klasifikasi Baku Lapangan Usaha Indonesia 5-digit untuk raw materials industry for traditional medicine (for humans). Termasuk dalam kategori Manufacturing Industry di bawah subgolongan Traditional Medicine Industry (golongan pokok 21) dalam taksonomi resmi KBLI 2020 yang dikelola Badan Pusat Statistik (BPS).
Setiap entitas, baik milik Indonesia maupun asing, yang berniat beroperasi di bidang raw materials industry for traditional medicine (for humans) sebagai kegiatan usaha utama atau sekunder wajib memilih kode ini pada NIB (Nomor Induk Berusaha). Kode yang dipilih menentukan instrumen perizinan yang dibutuhkan, otoritas penerbit, dan kewajiban kepatuhan berkelanjutan.
Pendekatan Berbasis Risiko OSS Indonesia menggunakan kode KBLI untuk menentukan tiga hal: (1) apakah investasi asing diizinkan dan dengan batas berapa, (2) instrumen perizinan berbasis risiko yang dibutuhkan, dan (3) otoritas yang menerbitkan setiap instrumen. Memilih kode yang salah dapat menunda atau membatalkan izin Anda.
BPS Indonesia menerbitkan taksonomi KBLI 2025 baru pada awal 2025. OSS, BKPM, dan kementerian operasional belum mengadopsinya — KBLI 2020 tetap menjadi standar aktif untuk pendaftaran usaha. Berikut apa yang akan datang untuk kode spesifik ini.
KBLI 21021 mempertahankan nomor kode dan ruang lingkup yang sama dalam taksonomi baru. Deskripsi kegiatan, hierarki, dan tujuan penggunaan kode tetap dipertahankan.
Ketika OSS mengadopsi KBLI 2025, kami akan memigrasi entitas yang ada ke kode pengganti yang sesuai sebagai bagian dari layanan kepatuhan berkelanjutan — tidak diperlukan tindakan dari pihak Anda sekarang.
Bicara dengan spesialisIndonesia's OSS Risk-Based Approach assigns a separate risk level for each of the four business scales. The licensing instruments required (NIB, Standard Certificate, Operating License) are determined by the risk level. Foreign-owned entities (PT PMA) must register at the Large scale, so the rightmost column applies to most foreign investors.
KBLI 21021 (Raw Materials Industry for Traditional Medicine (for Humans)) adalah kode Klasifikasi Baku Lapangan Usaha Indonesia 5-digit untuk raw materials industry for traditional medicine (for humans). Termasuk dalam kategori Manufacturing Industry dalam taksonomi resmi KBLI 2020 yang dikelola Badan Pusat Statistik (BPS).
Tidak — KBLI 21021 dicadangkan untuk modal Indonesia 100% berdasarkan Perpres 10/2021. Investor asing tidak dapat memegang saham di entitas yang beroperasi di bawah kode ini. Umum untuk industri tradisional, penyiaran, dan kegiatan signifikan secara budaya. Untuk pemegang saham WNI, KBLI ini sepenuhnya terbuka.
Tingkat risiko KBLI 21021 per skala usaha: Mikro High, Kecil High, Menengah High, Besar High. Perusahaan milik asing (PT PMA) wajib mendaftar di skala Besar.
Tidak berlaku untuk PT PMA — KBLI 21021 tidak dapat digunakan entitas milik asing, sehingga modal disetor minimum BKPM Reg. 5/2025 maupun aturan modal sektor khusus tidak relevan. Hambatan strukturalnya datang lebih dulu.
Tidak berlaku untuk PT PMA — KBLI 21021 tidak dapat digunakan entitas milik asing, jadi jadwal pendirian PT PMA 4-8 minggu tidak berlaku. Pindahkan ke kode saudara yang memiliki matriks skala Besar atau pertimbangkan struktur lain.
Ya — KBLI 21021 ada dalam daftar prioritas Tax Allowance (PP 78/2019). Layak pengurangan 30% penghasilan kena pajak selama 6 tahun plus percepatan penyusutan.
Tidak berlaku untuk PT PMA — KBLI 21021 tidak dapat digunakan entitas milik asing, sehingga OSS tidak menetapkan otoritas penerbit izin untuk PMA. Pendaftaran skala kecil (Mikro / Kecil) untuk operator Indonesia umumnya diterbitkan di tingkat Kabupaten / Kota.
Selain NIB, KBLI 21021 memiliki 1 izin PB UMKU di 1 regulator sektor: Pharmaceuticals (1). Sebagian besar operasi hanya membutuhkan 2-4 izin — rangkaian yang relevan tergantung aktivitas spesifik yang Anda jalankan; Emerhub memetakan subset yang tepat sebelum proses pengajuan.
KBLI dalam subgolongan yang sama 2102: 21022 (Traditional Medicine Product Industry for Humans); 21023 (Traditional Medicine Product Industry for Animals); 21024 (Raw Materials Industry for Traditional Medicine (for Animals)). Ini kegiatan yang berkaitan erat — lihat bagian kode terkait di bawah untuk daftar lengkap.